London Knightsbridge Cosmetic Clinic Limited 08265190 false 2024-11-01 2025-10-31 2025-10-31 The principal activity of the company is that of a clinic and the provision of non-surgical care. Digita Accounts Production Advanced 6.30.9574.0 true true 08265190 2024-11-01 2025-10-31 08265190 2025-10-31 08265190 bus:OrdinaryShareClass1 2025-10-31 08265190 bus:OtherShareClass1 2025-10-31 08265190 core:CurrentFinancialInstruments 2025-10-31 08265190 core:CurrentFinancialInstruments core:WithinOneYear 2025-10-31 08265190 core:Non-currentFinancialInstruments 2025-10-31 08265190 core:Non-currentFinancialInstruments core:AfterOneYear 2025-10-31 08265190 core:OtherResidualIntangibleAssets 2025-10-31 08265190 core:FurnitureFittings 2025-10-31 08265190 bus:SmallEntities 2024-11-01 2025-10-31 08265190 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 08265190 bus:FilletedAccounts 2024-11-01 2025-10-31 08265190 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 08265190 bus:RegisteredOffice 2024-11-01 2025-10-31 08265190 bus:Director1 2024-11-01 2025-10-31 08265190 bus:OrdinaryShareClass1 2024-11-01 2025-10-31 08265190 bus:OtherShareClass1 2024-11-01 2025-10-31 08265190 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 08265190 core:IntangibleAssetsOtherThanGoodwill 2024-11-01 2025-10-31 08265190 core:FurnitureFittings 2024-11-01 2025-10-31 08265190 core:OfficeEquipment 2024-11-01 2025-10-31 08265190 countries:AllCountries 2024-11-01 2025-10-31 08265190 2024-10-31 08265190 core:OtherResidualIntangibleAssets 2024-10-31 08265190 core:FurnitureFittings 2024-10-31 08265190 2023-11-01 2024-10-31 08265190 2024-10-31 08265190 bus:OrdinaryShareClass1 2024-10-31 08265190 bus:OtherShareClass1 2024-10-31 08265190 core:CurrentFinancialInstruments 2024-10-31 08265190 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 08265190 core:Non-currentFinancialInstruments 2024-10-31 08265190 core:Non-currentFinancialInstruments core:AfterOneYear 2024-10-31 08265190 core:FurnitureFittings 2024-10-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 08265190

London Knightsbridge Cosmetic Clinic Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 October 2025

 

London Knightsbridge Cosmetic Clinic Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 10

 

London Knightsbridge Cosmetic Clinic Limited

Company Information

Director

Dr Salinda Johnson

Registered office

176-178 Pontefract Road
Cudworth
Barnsley
South Yorkshire
S72 8BE

Accountants

Thorntons Accounting Limited
Chartered Certified Accountants
176-178 Pontefract Road
Cudworth
Barnsley
South Yorkshire
S72 8BE

 

London Knightsbridge Cosmetic Clinic Limited

(Registration number: 08265190)
Balance Sheet as at 31 October 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

5

79,996

37,199

Current assets

 

Stocks

6

39,000

24,000

Debtors

7

175,035

128,427

Cash at bank and in hand

 

49,956

50,437

 

263,991

202,864

Creditors: Amounts falling due within one year

8

(287,003)

(128,869)

Net current (liabilities)/assets

 

(23,012)

73,995

Total assets less current liabilities

 

56,984

111,194

Creditors: Amounts falling due after more than one year

8

(10,655)

(19,604)

Provisions for liabilities

(5,440)

(5,440)

Net assets

 

40,889

86,150

Capital and reserves

 

Called up share capital

9

101

101

Retained earnings

40,788

86,049

Shareholders' funds

 

40,889

86,150

For the financial year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 11 May 2026
 

 

London Knightsbridge Cosmetic Clinic Limited

(Registration number: 08265190)
Balance Sheet as at 31 October 2025

.........................................
Dr Salinda Johnson
Director

 

London Knightsbridge Cosmetic Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
176-178 Pontefract Road
Cudworth
Barnsley
South Yorkshire
S72 8BE
United Kingdom

These financial statements were authorised for issue by the director on 11 May 2026.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

 

London Knightsbridge Cosmetic Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

20% Straight line

Fixtures and fittings

20% Straight line

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Intangible assets

20% Straght line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

 

London Knightsbridge Cosmetic Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 9 (2024 - 9).

 

London Knightsbridge Cosmetic Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

4

Intangible assets

Other intangible assets
 £

Total
£

Cost or valuation

At 1 November 2024

3,810

3,810

At 31 October 2025

3,810

3,810

Amortisation

At 1 November 2024

3,810

3,810

At 31 October 2025

3,810

3,810

Carrying amount

At 31 October 2025

-

-

5

Tangible assets

Fixtures and fittings
£

Total
£

Cost or valuation

At 1 November 2024

297,294

297,294

Additions

82,097

82,097

At 31 October 2025

379,391

379,391

Depreciation

At 1 November 2024

260,095

260,095

Charge for the year

39,300

39,300

At 31 October 2025

299,395

299,395

Carrying amount

At 31 October 2025

79,996

79,996

At 31 October 2024

37,199

37,199

6

Stocks

2025
£

2024
£

Other inventories

39,000

24,000

 

London Knightsbridge Cosmetic Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

7

Debtors

2025
£

2024
£

Trade debtors

20,739

-

Other debtors

26,255

386

Prepayments

128,041

128,041

175,035

128,427

 

London Knightsbridge Cosmetic Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

8

Creditors

Creditors: amounts falling due within one year

2025
£

2024
£

Due within one year

Taxation and social security

5,475

40,206

Accruals and deferred income

3,340

3,054

Other creditors

278,188

85,609

287,003

128,869

Creditors: amounts falling due after more than one year

Note

2025
£

2024
£

Due after one year

 

Loans and borrowings

10

10,655

19,604

9

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary of £1 each

100

100

100

100

B class of £1 each

1

1

1

1

101

101

101

101

10

Loans and borrowings

Non-current loans and borrowings

2025
£

2024
£

Bank borrowings

10,655

19,604

11

Related party transactions

Director's remuneration

The director's remuneration for the year was as follows:

 

London Knightsbridge Cosmetic Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

2025
£

2024
£

Remuneration

13,815

13,678

Contributions paid to money purchase schemes

-

4,000

13,815

17,678